LymphedemaV1, PascalFrancis, Curation, bibRecord, 000828

Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study

Identifieur interne : 000828 ( PascalFrancis/Curation ); précédent : 000827; suivant : 000829

Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study

Auteurs : Rehana L. Ahmed [États-Unis] ; Kathryn H. Schmitz [États-Unis] ; Anna E. Prizment [États-Unis] ; Aaron R. Folsom [États-Unis]

Source :

Breast cancer research and treatment [ 0167-6806 ] ; 2011.

RBID : Pascal:12-0019486

Descripteurs français

Pascal (Inist)
- Facteur risque, Epidémiologie, Lymphoedème, Cancer du sein, Homme, Survivant, Iowa, Femelle, Adulte, Femme, Santé.
Wicri :
- topic : Homme, Adulte, Femme.

English descriptors

KwdEn :
- Adult, Breast cancer, Epidemiology, Female, Health, Human, Iowa, Lymphedema, Risk factor, Survivor, Woman.

Abstract

Risk factors for lymphedema and related arm symptoms in breast cancer (BC) survivors have not been examined using a large prospective population-based cohort. The Iowa Women's Health Study (IWHS) collected self-reported data for diagnosed lymphedema in 2004, and data for cancer diagnosis, treatment, behavioral and health characteristics between 1986 and 2003. We studied 1,287 women, aged 55-69 at baseline, who developed unilateral BC: n = 104 (8%) with diagnosed lymphedema, n = 475 (37%) with arm symptoms but without diagnosed lymphedema, and n = 708 without lymphedema. Age- and multivariate-adjusted logistic regression models examined risk factors for lymphedema and related arm symptoms (OR [95% confidence interval]). The mean time between BC and the 2004 survey was 8.1 ± 5.0 (mean ± SD) years. After multivariate adjustment, the following cancer characteristics were positively associated with lymphedema: tumor stage (regional vs. in situ: 3.92 [1.61-9.54]), number of excised nodes (highest vs. lowest quintile: 3.52 [1.32-9.34], P_trend = 0.003), tumor-positive nodes (yes vs. no 2.12 [1.19, 3.79]), and adjuvant chemotherapy (yes vs. no: 3.05 [1.75-5.30]). Several health characteristics were positively associated with lymphedema: baseline body mass index (highest vs. lowest tertile: 3.24 [1.70-6.21]), waist and hip circumference, and general health (fair/poor vs. excellent: 3.44 [1.30-9.06]). Positive associations with arm symptoms were number of excised nodes (highest vs. lowest quintile: 2.38 [1.41-.03], P_trend = 0.007), axillary radiation (yes vs. no: 1.72 [1.15-2.57]), and baseline general health (fair/poor vs. excellent: 4.27 [2.60-7.00]). In the IWHS, obesity, poorer general health, and markers of more advanced cancer were risk factors for lymphedema and related arm symptoms in BC survivors.

A01	`01`	`1`		`@0 0167-6806`
A02	`01`			`@0 BCTRD6`
A03		`1`		`@0 Breast cancer res. treat.`
A05				`@2 130`
A06				`@2 3`
A08	`01`	`1`	`ENG`	`@1 Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study`
A11	`01`	`1`		`@1 AHMED (Rehana L.)`
A11	`02`	`1`		`@1 SCHMITZ (Kathryn H.)`
A11	`03`	`1`		`@1 PRIZMENT (Anna E.)`
A11	`04`	`1`		`@1 FOLSOM (Aaron R.)`
A14	`01`			`@1 Department of Dermatology, University of Minnesota, Mayo Mail Code 98, 420 Delaware Street SE @2 Minneapolis, MN 55455-0392 @3 USA @Z 1 aut.`
A14	`02`			`@1 Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, 921 Blockley Hall, 423 Guardian Drive @2 Philadelphia, PA 19104 @3 USA @Z 2 aut.`
A14	`03`			`@1 Division of Epidemiology and Community Health, The University of Minnesota, 1300 S Second Street, Suite 300 @2 Minneapolis, MN 55454 @3 USA @Z 3 aut. @Z 4 aut.`
A20				`@1 981-991`
A21				`@1 2011`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 20699 @5 354000507339490280`
A44				`@0 0000 @1 © 2012 INIST-CNRS. All rights reserved.`
A45				`@0 40 ref.`
A47	`01`	`1`		`@0 12-0019486`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Breast cancer research and treatment`
A66	`01`			`@0 NLD`
C01	`01`		`ENG`	@0 Risk factors for lymphedema and related arm symptoms in breast cancer (BC) survivors have not been examined using a large prospective population-based cohort. The Iowa Women's Health Study (IWHS) collected self-reported data for diagnosed lymphedema in 2004, and data for cancer diagnosis, treatment, behavioral and health characteristics between 1986 and 2003. We studied 1,287 women, aged 55-69 at baseline, who developed unilateral BC: n = 104 (8%) with diagnosed lymphedema, n = 475 (37%) with arm symptoms but without diagnosed lymphedema, and n = 708 without lymphedema. Age- and multivariate-adjusted logistic regression models examined risk factors for lymphedema and related arm symptoms (OR [95% confidence interval]). The mean time between BC and the 2004 survey was 8.1 ± 5.0 (mean ± SD) years. After multivariate adjustment, the following cancer characteristics were positively associated with lymphedema: tumor stage (regional vs. in situ: 3.92 [1.61-9.54]), number of excised nodes (highest vs. lowest quintile: 3.52 [1.32-9.34], P_trend = 0.003), tumor-positive nodes (yes vs. no 2.12 [1.19, 3.79]), and adjuvant chemotherapy (yes vs. no: 3.05 [1.75-5.30]). Several health characteristics were positively associated with lymphedema: baseline body mass index (highest vs. lowest tertile: 3.24 [1.70-6.21]), waist and hip circumference, and general health (fair/poor vs. excellent: 3.44 [1.30-9.06]). Positive associations with arm symptoms were number of excised nodes (highest vs. lowest quintile: 2.38 [1.41-.03], P_trend = 0.007), axillary radiation (yes vs. no: 1.72 [1.15-2.57]), and baseline general health (fair/poor vs. excellent: 4.27 [2.60-7.00]). In the IWHS, obesity, poorer general health, and markers of more advanced cancer were risk factors for lymphedema and related arm symptoms in BC survivors.
C02	`01`	`X`		`@0 002B20E02`
C02	`02`	`X`		`@0 002B12B04`
C03	`01`	`X`	`FRE`	`@0 Facteur risque @5 01`
C03	`01`	`X`	`ENG`	`@0 Risk factor @5 01`
C03	`01`	`X`	`SPA`	`@0 Factor riesgo @5 01`
C03	`02`	`X`	`FRE`	`@0 Epidémiologie @5 02`
C03	`02`	`X`	`ENG`	`@0 Epidemiology @5 02`
C03	`02`	`X`	`SPA`	`@0 Epidemiología @5 02`
C03	`03`	`X`	`FRE`	`@0 Lymphoedème @5 03`
C03	`03`	`X`	`ENG`	`@0 Lymphedema @5 03`
C03	`03`	`X`	`SPA`	`@0 Linfedema @5 03`
C03	`04`	`X`	`FRE`	`@0 Cancer du sein @2 NM @5 04`
C03	`04`	`X`	`ENG`	`@0 Breast cancer @2 NM @5 04`
C03	`04`	`X`	`SPA`	`@0 Cáncer del pecho @2 NM @5 04`
C03	`05`	`X`	`FRE`	`@0 Homme @5 05`
C03	`05`	`X`	`ENG`	`@0 Human @5 05`
C03	`05`	`X`	`SPA`	`@0 Hombre @5 05`
C03	`06`	`X`	`FRE`	`@0 Survivant @5 06`
C03	`06`	`X`	`ENG`	`@0 Survivor @5 06`
C03	`06`	`X`	`SPA`	`@0 Sobreviviente @5 06`
C03	`07`	`X`	`FRE`	`@0 Iowa @2 NG @5 07`
C03	`07`	`X`	`ENG`	`@0 Iowa @2 NG @5 07`
C03	`07`	`X`	`SPA`	`@0 Iowa @2 NG @5 07`
C03	`08`	`X`	`FRE`	`@0 Femelle @5 08`
C03	`08`	`X`	`ENG`	`@0 Female @5 08`
C03	`08`	`X`	`SPA`	`@0 Hembra @5 08`
C03	`09`	`X`	`FRE`	`@0 Adulte @5 09`
C03	`09`	`X`	`ENG`	`@0 Adult @5 09`
C03	`09`	`X`	`SPA`	`@0 Adulto @5 09`
C03	`10`	`X`	`FRE`	`@0 Femme @5 10`
C03	`10`	`X`	`ENG`	`@0 Woman @5 10`
C03	`10`	`X`	`SPA`	`@0 Mujer @5 10`
C03	`11`	`X`	`FRE`	`@0 Santé @5 11`
C03	`11`	`X`	`ENG`	`@0 Health @5 11`
C03	`11`	`X`	`SPA`	`@0 Salud @5 11`
C07	`01`	`X`	`FRE`	`@0 Etats-Unis @2 NG`
C07	`01`	`X`	`ENG`	`@0 United States @2 NG`
C07	`01`	`X`	`SPA`	`@0 Estados Unidos @2 NG`
C07	`02`	`X`	`FRE`	`@0 Amérique du Nord @2 NG`
C07	`02`	`X`	`ENG`	`@0 North America @2 NG`
C07	`02`	`X`	`SPA`	`@0 America del norte @2 NG`
C07	`03`	`X`	`FRE`	`@0 Amérique @2 NG`
C07	`03`	`X`	`ENG`	`@0 America @2 NG`
C07	`03`	`X`	`SPA`	`@0 America @2 NG`
C07	`04`	`X`	`FRE`	`@0 Pathologie de l'appareil circulatoire @5 37`
C07	`04`	`X`	`ENG`	`@0 Cardiovascular disease @5 37`
C07	`04`	`X`	`SPA`	`@0 Aparato circulatorio patología @5 37`
C07	`05`	`X`	`FRE`	`@0 Pathologie des vaisseaux lymphatiques @5 38`
C07	`05`	`X`	`ENG`	`@0 Lymphatic vessel disease @5 38`
C07	`05`	`X`	`SPA`	`@0 Linfático patología @5 38`
C07	`06`	`X`	`FRE`	`@0 Tumeur maligne @2 NM @5 39`
C07	`06`	`X`	`ENG`	`@0 Malignant tumor @2 NM @5 39`
C07	`06`	`X`	`SPA`	`@0 Tumor maligno @2 NM @5 39`
C07	`07`	`X`	`FRE`	`@0 Cancer @2 NM`
C07	`07`	`X`	`ENG`	`@0 Cancer @2 NM`
C07	`07`	`X`	`SPA`	`@0 Cáncer @2 NM`
C07	`08`	`X`	`FRE`	`@0 Pathologie de la glande mammaire @2 NM @5 40`
C07	`08`	`X`	`ENG`	`@0 Mammary gland diseases @2 NM @5 40`
C07	`08`	`X`	`SPA`	`@0 Glándula mamaria patología @2 NM @5 40`
C07	`09`	`X`	`FRE`	`@0 Pathologie du sein @2 NM @5 41`
C07	`09`	`X`	`ENG`	`@0 Breast disease @2 NM @5 41`
C07	`09`	`X`	`SPA`	`@0 Seno patología @2 NM @5 41`
N21				`@1 002`
N44	`01`			`@1 OTO`
N82				`@1 OTO`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000129

Links to Exploration step

Pascal:12-0019486

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study</title>
<author><name sortKey="Ahmed, Rehana L" sort="Ahmed, Rehana L" uniqKey="Ahmed R" first="Rehana L." last="Ahmed">Rehana L. Ahmed</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Dermatology, University of Minnesota, Mayo Mail Code 98, 420 Delaware Street SE</s1>
<s2>Minneapolis, MN 55455-0392</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H." last="Schmitz">Kathryn H. Schmitz</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, 921 Blockley Hall, 423 Guardian Drive</s1>
<s2>Philadelphia, PA 19104</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Prizment, Anna E" sort="Prizment, Anna E" uniqKey="Prizment A" first="Anna E." last="Prizment">Anna E. Prizment</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Epidemiology and Community Health, The University of Minnesota, 1300 S Second Street, Suite 300</s1>
<s2>Minneapolis, MN 55454</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Folsom, Aaron R" sort="Folsom, Aaron R" uniqKey="Folsom A" first="Aaron R." last="Folsom">Aaron R. Folsom</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Epidemiology and Community Health, The University of Minnesota, 1300 S Second Street, Suite 300</s1>
<s2>Minneapolis, MN 55454</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">12-0019486</idno>
<date when="2011">2011</date>
<idno type="stanalyst">PASCAL 12-0019486 INIST</idno>
<idno type="RBID">Pascal:12-0019486</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000129</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000828</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study</title>
<author><name sortKey="Ahmed, Rehana L" sort="Ahmed, Rehana L" uniqKey="Ahmed R" first="Rehana L." last="Ahmed">Rehana L. Ahmed</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Department of Dermatology, University of Minnesota, Mayo Mail Code 98, 420 Delaware Street SE</s1>
<s2>Minneapolis, MN 55455-0392</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Schmitz, Kathryn H" sort="Schmitz, Kathryn H" uniqKey="Schmitz K" first="Kathryn H." last="Schmitz">Kathryn H. Schmitz</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, 921 Blockley Hall, 423 Guardian Drive</s1>
<s2>Philadelphia, PA 19104</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Prizment, Anna E" sort="Prizment, Anna E" uniqKey="Prizment A" first="Anna E." last="Prizment">Anna E. Prizment</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Epidemiology and Community Health, The University of Minnesota, 1300 S Second Street, Suite 300</s1>
<s2>Minneapolis, MN 55454</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Folsom, Aaron R" sort="Folsom, Aaron R" uniqKey="Folsom A" first="Aaron R." last="Folsom">Aaron R. Folsom</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Division of Epidemiology and Community Health, The University of Minnesota, 1300 S Second Street, Suite 300</s1>
<s2>Minneapolis, MN 55454</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
<imprint><date when="2011">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Breast cancer research and treatment</title>
<title level="j" type="abbreviated">Breast cancer res. treat.</title>
<idno type="ISSN">0167-6806</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Breast cancer</term>
<term>Epidemiology</term>
<term>Female</term>
<term>Health</term>
<term>Human</term>
<term>Iowa</term>
<term>Lymphedema</term>
<term>Risk factor</term>
<term>Survivor</term>
<term>Woman</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Facteur risque</term>
<term>Epidémiologie</term>
<term>Lymphoedème</term>
<term>Cancer du sein</term>
<term>Homme</term>
<term>Survivant</term>
<term>Iowa</term>
<term>Femelle</term>
<term>Adulte</term>
<term>Femme</term>
<term>Santé</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Adulte</term>
<term>Femme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Risk factors for lymphedema and related arm symptoms in breast cancer (BC) survivors have not been examined using a large prospective population-based cohort. The Iowa Women's Health Study (IWHS) collected self-reported data for diagnosed lymphedema in 2004, and data for cancer diagnosis, treatment, behavioral and health characteristics between 1986 and 2003. We studied 1,287 women, aged 55-69 at baseline, who developed unilateral BC: n = 104 (8%) with diagnosed lymphedema, n = 475 (37%) with arm symptoms but without diagnosed lymphedema, and n = 708 without lymphedema. Age- and multivariate-adjusted logistic regression models examined risk factors for lymphedema and related arm symptoms (OR [95% confidence interval]). The mean time between BC and the 2004 survey was 8.1 ± 5.0 (mean ± SD) years. After multivariate adjustment, the following cancer characteristics were positively associated with lymphedema: tumor stage (regional vs. in situ: 3.92 [1.61-9.54]), number of excised nodes (highest vs. lowest quintile: 3.52 [1.32-9.34], P<sub>trend</sub>
 = 0.003), tumor-positive nodes (yes vs. no 2.12 [1.19, 3.79]), and adjuvant chemotherapy (yes vs. no: 3.05 [1.75-5.30]). Several health characteristics were positively associated with lymphedema: baseline body mass index (highest vs. lowest tertile: 3.24 [1.70-6.21]), waist and hip circumference, and general health (fair/poor vs. excellent: 3.44 [1.30-9.06]). Positive associations with arm symptoms were number of excised nodes (highest vs. lowest quintile: 2.38 [1.41-.03], P<sub>trend</sub>
 = 0.007), axillary radiation (yes vs. no: 1.72 [1.15-2.57]), and baseline general health (fair/poor vs. excellent: 4.27 [2.60-7.00]). In the IWHS, obesity, poorer general health, and markers of more advanced cancer were risk factors for lymphedema and related arm symptoms in BC survivors.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0167-6806</s0>
</fA01>
<fA02 i1="01"><s0>BCTRD6</s0>
</fA02>
<fA03 i2="1"><s0>Breast cancer res. treat.</s0>
</fA03>
<fA05><s2>130</s2>
</fA05>
<fA06><s2>3</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>AHMED (Rehana L.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>SCHMITZ (Kathryn H.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>PRIZMENT (Anna E.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>FOLSOM (Aaron R.)</s1>
</fA11>
<fA14 i1="01"><s1>Department of Dermatology, University of Minnesota, Mayo Mail Code 98, 420 Delaware Street SE</s1>
<s2>Minneapolis, MN 55455-0392</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, 921 Blockley Hall, 423 Guardian Drive</s1>
<s2>Philadelphia, PA 19104</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Division of Epidemiology and Community Health, The University of Minnesota, 1300 S Second Street, Suite 300</s1>
<s2>Minneapolis, MN 55454</s2>
<s3>USA</s3>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA20><s1>981-991</s1>
</fA20>
<fA21><s1>2011</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>20699</s2>
<s5>354000507339490280</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 2012 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>40 ref.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>12-0019486</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Breast cancer research and treatment</s0>
</fA64>
<fA66 i1="01"><s0>NLD</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>Risk factors for lymphedema and related arm symptoms in breast cancer (BC) survivors have not been examined using a large prospective population-based cohort. The Iowa Women's Health Study (IWHS) collected self-reported data for diagnosed lymphedema in 2004, and data for cancer diagnosis, treatment, behavioral and health characteristics between 1986 and 2003. We studied 1,287 women, aged 55-69 at baseline, who developed unilateral BC: n = 104 (8%) with diagnosed lymphedema, n = 475 (37%) with arm symptoms but without diagnosed lymphedema, and n = 708 without lymphedema. Age- and multivariate-adjusted logistic regression models examined risk factors for lymphedema and related arm symptoms (OR [95% confidence interval]). The mean time between BC and the 2004 survey was 8.1 ± 5.0 (mean ± SD) years. After multivariate adjustment, the following cancer characteristics were positively associated with lymphedema: tumor stage (regional vs. in situ: 3.92 [1.61-9.54]), number of excised nodes (highest vs. lowest quintile: 3.52 [1.32-9.34], P<sub>trend</sub>
 = 0.003), tumor-positive nodes (yes vs. no 2.12 [1.19, 3.79]), and adjuvant chemotherapy (yes vs. no: 3.05 [1.75-5.30]). Several health characteristics were positively associated with lymphedema: baseline body mass index (highest vs. lowest tertile: 3.24 [1.70-6.21]), waist and hip circumference, and general health (fair/poor vs. excellent: 3.44 [1.30-9.06]). Positive associations with arm symptoms were number of excised nodes (highest vs. lowest quintile: 2.38 [1.41-.03], P<sub>trend</sub>
 = 0.007), axillary radiation (yes vs. no: 1.72 [1.15-2.57]), and baseline general health (fair/poor vs. excellent: 4.27 [2.60-7.00]). In the IWHS, obesity, poorer general health, and markers of more advanced cancer were risk factors for lymphedema and related arm symptoms in BC survivors.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B20E02</s0>
</fC02>
<fC02 i1="02" i2="X"><s0>002B12B04</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Facteur risque</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Risk factor</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Factor riesgo</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Epidémiologie</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Epidemiology</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Epidemiología</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Lymphoedème</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Lymphedema</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Linfedema</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Cancer du sein</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Breast cancer</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Cáncer del pecho</s0>
<s2>NM</s2>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Homme</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Human</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Hombre</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Survivant</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Survivor</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Sobreviviente</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Iowa</s0>
<s2>NG</s2>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Iowa</s0>
<s2>NG</s2>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Iowa</s0>
<s2>NG</s2>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE"><s0>Femelle</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG"><s0>Female</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA"><s0>Hembra</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE"><s0>Adulte</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG"><s0>Adult</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA"><s0>Adulto</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE"><s0>Femme</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG"><s0>Woman</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA"><s0>Mujer</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE"><s0>Santé</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG"><s0>Health</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA"><s0>Salud</s0>
<s5>11</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Etats-Unis</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>United States</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Estados Unidos</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Amérique du Nord</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>North America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>America del norte</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Amérique</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Pathologie de l'appareil circulatoire</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Cardiovascular disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Aparato circulatorio patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Pathologie des vaisseaux lymphatiques</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Lymphatic vessel disease</s0>
<s5>38</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Linfático patología</s0>
<s5>38</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Tumeur maligne</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Malignant tumor</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Tumor maligno</s0>
<s2>NM</s2>
<s5>39</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Cancer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Cáncer</s0>
<s2>NM</s2>
</fC07>
<fC07 i1="08" i2="X" l="FRE"><s0>Pathologie de la glande mammaire</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="ENG"><s0>Mammary gland diseases</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="08" i2="X" l="SPA"><s0>Glándula mamaria patología</s0>
<s2>NM</s2>
<s5>40</s5>
</fC07>
<fC07 i1="09" i2="X" l="FRE"><s0>Pathologie du sein</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fC07 i1="09" i2="X" l="ENG"><s0>Breast disease</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fC07 i1="09" i2="X" l="SPA"><s0>Seno patología</s0>
<s2>NM</s2>
<s5>41</s5>
</fC07>
<fN21><s1>002</s1>
</fN21>
<fN44 i1="01"><s1>OTO</s1>
</fN44>
<fN82><s1>OTO</s1>
</fN82>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000828 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 000828 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:12-0019486
   |texte=   Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study
}}

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study

Risk factors for lymphedema in breast cancer survivors, the Iowa Women's Health Study

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri